Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
CanSino Biologics, Inc. Class H
6185Health technology
$2B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, CanSino Biologics, Inc. Class H appears to be Failed.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)44.56%
Non-Shariah Cash Items
Cash And Cash Equivalents$1.6B
Other Short Term Investments$1.6B
Restricted Cash$10.2M
Liabilities (<30%)27.98%
Non-Shariah Liabilities
Current Capital Lease Obligation$10M
Long Term Debt$1.1B
Long Term Capital Lease Obligation$12.7M
Current Debt$892.2M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
